A clinical, cytogenetic, and molecular study has been carried out on 40 adults with a firm diagnosis of Prader-Willi syndrome. A cytogenetically detectable deletion was observed in 58% while further subjects had a deletion which was detectable by molecular methods only, giving a total of 76%. Four cases of maternal uniparental disomy (UPD) were all female. Three of them were heterodisomic while the fourth was isodisomic. Two male probands were heterozygous at all loci tested yet did not have UPD. Although methylation studies showed that one of them had a single band using probe PW71, the other one had two bands. Psychiatric studies suggest that females with maternal UPD are indistinguishable psychologically from those with a paternal deletion in 15qIIqI3.
First described in 1956,' Prader-Willi syndrome (PWS) is the commonest syndromal cause of obesity. In adults the clinical picture includes hypogonadism, short stature, small hands and feet, hypopigmentation, cognitive impairment, and hyperphagia.2 Obesity is usually the most prominent physical characteristic of PWS probands and is a major factor in the health problems experienced by them. These may include hypertension, cardiovascular compromise, and diabetes mellitus. Other problems include skin picking (which may be sufficiently serious to cause infections), scoliosis, and eye and dental problems. Most affected people have cognitive impairment and IQs between 60 and 90. Some have severe mental retardation, others have IQs within the normal range. '4 Most cases of PWS are sporadic, although occasional affected sib pairs have been described.5 PWS is associated with a loss of the paternal contribution in 15qllql3, resulting from de novo deletion of the paternally derived chromosome 1567 or from maternal uniparental disomy (UPD).8 High resolution banding techniques have shown that the majority of probands have a de novo deletion of the proximal long arm of the paternally inherited chro- mosome 15 , and that other chromosomal abnormalities involving proximal chromosome 15 may account for a further 5% of cases.9 Molecular studies have suggested that most of the remaining cases have maternal UPD.10 Angelman syndrome (AS), although clinically completely distinct from PWS, is associated with a similar deletion in 15qllql3, which is always maternally derived,11 or with paternal UPD.'2 Thus PWS and its "sister" syndrome, Angelman syndrome (AS) have apparently similar loss of material in 15qllql3 derived from opposite parents suggesting that imprinting of one or more genes within the region is of importance in their expression. Parent specific imprinting results in the differential expression of genes depending on the parent of origin. The oppositely imprinted Prader-Willi critical region (PWSCR) and Angelman syndrome critical region (ASCR)
are not allelic but contiguous, with the PWSCR lying proximal to the ASCR."3 The majority of the deletions detected in both syndromes, however, encompass both critical regions and have similar breakpoints. So, although the two syndromes are distinct, they often share a common deleted region. 13 It has been suggested that hypopigmentation is associated with deletions which include D15S12,'4 but there appears to be no obvious clinical distinction between PWS probands who have a visible 1 5ql 1q1 3 deletion and those who have maternal UPD.'0 GABRB3 and GABRA5, although both located in the Angelman syndrome region,5 16 are not considered to be candidate genes for AS,'7 but the location of the SNRPN gene within the critical region for PWS has identified a possible candidate gene which is expressed in the brain, and would exert a pleiotropic effect.'8 Despite this, both PWS and AS are likely to be contiguous gene syndromes.
Because a firm clinical diagnosis of PWS can be difficult in a child and because comparisons of cognitive function are more appropriate in adults, a series of 40 adult probands (age range 16 to 40) with a clinical diagnosis of PraderWilli syndrome were studied with the following aims: (1) to describe the nature of genetic abnormalities occurring; (2) to characterise the extent and location of deletions within 15qllql3; and (3) to assess the influence, if any, of the nature and size of genetic abnormalities on physical and cognitive characteristics.
Materials and methods

PHYSICAL AND COGNITIVE ASSESSMENT
All of the probands who participated in this study had a diagnosis ofPrader-Willi syndrome. To determine whether they fulfilled the diagnostic criteria laid down for PWS they were examined physically and the following information noted: height, weight, standard hand, foot, and eye measurements; testis size in males and menstrual history in females; neonatal feeding history and presence or absence of severe hypotonia during the neonatal period; medical and orthopaedic history. Verbal and non-verbal cognitive abilities were assessed using the Raven's Coloured Matrices or Raven's Standard Progressive Matrices (measures of non-verbal cognitive ability)1920 and the matching (Crichton or Mill Hill) vocabulary scale (measures of verbal cognitive ability)."2 22 Adaptive behaviour was assessed using the Vineland adaptive behaviour scales. 23 The clinician making the assessments was unaware of the genetic results in all but one case.
CYTOGENETIC STUDIES
Chromosomes were studied by high resolution at the 850 band level. Samples were obtained from the probands, and where possible from both of their parents and any sibs who were available for study. Culture conditions were optimised to obtain prometaphase chromosomes by synchronising cell division with an excess of thymidine or by treatment with ethidium bromide. Harvesting and slide making were by standard methods and the chromosome spreads studied by GTG, RBG, Ag/ NOR, distamycin/DAPI, and in some cases by fluorescence in situ hybridisation (FISH). All staining procedures used standard methods and FISH was carried out according to manufacturer's instructions using probes from the critical regions (ONCOR). was amplified using one 32P-labelled and one unlabelled primer. After amplification, an aliquot of PCR product was analysed by denaturing polyacrylamide gel electrophoresis and the polymorphic bands detected by autoradiography at -70°C. Chromosome 15 probes used for RFLP analysis in 15ql1ql3 included pML34 (D15S9), pTD3-21 (D15S1O), pIR4-3R (D15S11), PIR10-1 (D15S12),andpTD189-1 (D15S13). PCR was carried out using primers detecting microsatellite repeats in the loci D15S11, GABRB3, and GABRA5. Maternal disomy was detected by investigating loci outside the PWSCR. These included D15S24, D15S86, and a (CA)n repeat within the ACTC (cardiac muscle, alpha actin) gene. Methylation studies at locus DI 5S63 using probe PW71 were carried out on two probands as described by Dittrich et al.24 Results Forty probands with Prader-Willi syndrome and their families participated in the study. All probands had received a diagnosis of PWS from at least one clinician who was not involved in the study and all had a history of neonatal hypotonia and feeding difficulty. A clinical assessment was made of each proband according to criteria laid downl' and cognitive and behavioural assessments were performed on 20 subjects. Although the accepted diagnostic criteria were used in the assessment of each proband, because the study was aimed at a comparison of physical, behavioural, cytogenetic, and molecular investigations, these criteria could not be used in the differentiation of the probands as having Prader-Willi syndrome or not, as a circular argument would have ensued. Subsequent to cytogenetic and molecular studies they were divided into groups ( somy were detected among the 40 probands 
